Purpose: The present study aims radiological aspects of the occurrence of osteonecrosis of the jaw age groups both in receiving i.v bisphosphonates tratment Imaging assessment of bisphosphonates therapy-induced osteonecrosis of the jaw it is important to differentiate neoplastic invasion, osteomyelitis, osteoradionecrosis induced by radiation or bone related pathology of general diseases.
Material and method: We conducted a retrospective clinical study including 22 patients (8 men and 14 women) with various stages of osteonecrosis of the jaw.
Results: Radiological examinations using CBCT are required in all therapeutic approach of osteonecrosis of jaw cases providing accurate informations of position, dimension and the link with anatomical structures.Our study showed that the prevalence of osteonecrosis of mandibular growth is higher in women than in men and the risk of osteonecrosis of the jaw in appearance is depending on age factor witch occurs more often between age 52-59 and 73-80 years old.
Conclusion: The multitude of complications due to treatment with bisphosphonates bind to an early and specialized therapeutic approach. Radiological examinations is a first choice in the detection and early diagnosis of osteonecrosis of the jaw, patients requiring a permanent supervision by the physician and dentist.
1. Hamada H, Matsuo A, Koizumi T, Satomi T, Chikazu D. A simple evaluation method for early detection of bisphosphonaterelated osteonecrosis of the mandible using computed tomography. Journal of Cranio-Maxillo- Facial Surgery.2014:1-5.
2. Malden N, Pai AY. Oral bisphosphonate associated osteonecrosis of the jaws: three case reports. British Dental Journal. 2007;203(2):93-96.
3. Graham R, Russell G. Bisphosphonates: Mode of Action and Pharmacology. Pediatrics, 2007;119 (suppl. 2):150-162.
4. Yamashita J, McCauley LK. Antiresorptives and Osteonecrosis of the Jaw. J Evid Base Dent Pract. 2012;S1:233-247.
5. Sharma D, Ivanovski S, Slevin M, et al. Bisphosphonate-related osteonecrosis of jaw (BRONJ): diagnostic criteria and possible pathogenic mechanisms of an unexpected anti-angiogenic side effect. Vascular Cell. 2013;5(1):1-8.
6. Petcu EP, Ivanovski S, Wright RG, Slevin M, Miroiu R, Brinzaniuc K. Bisphosphonate-related osteonecrosis of jaw (BRONJ): an antiangiogenic side-effect? Diagnostic Pathology. 2012;7(78):1-3.
7. Sarasquete ME, Gonzalez M, San Miguel JF, Garcıa-Sanz R. Bisphosphonate-related osteonecrosis: genetic and acquired risk factors. Oral Dis. 2009;15:382-387.
8. Arce K, Assael LA, Weissman JL, Markiewicz MR. Imaging Findings in Bisphosphonate-Related Osteonecrosis of Jaws. American Association of Oral and Maxillofacial Surgeons. 2009:76-78.
9. Ferrara F, Califano L. Current perspectives in the management of patients with drug-induced osteonecrosis of the maxilla: experience of the school of Naples. BMC Geriatrics. 2010;10(supl.10):A56.
10. Torres SR, Chen CSK, Leroux BG, Lee PP, Hollender LG, Schubert MM. Fractal dimension evaluation of cone beam computed tomography in patients with bisphosphonate-associated osteonecrosis. Dentomaxillofacial Radiology. 2011;40:501-505.
11. Stockmann P, Hinkmann FM, Lell MM, et al. Panoramic radiograph, computed tomography or magnetic resonance imaging. Which imaging technique should be preferred in bisphosphonate-associated osteonecrosis of the jaw? A prospective clinical study. Clin Oral Invest. 2010;14:311-317.
12. Otto S, Sotlar K, Ehrenfeld M, Pautke C. Osteonecrosis of the jaw as a possible rare side effect of annual bisphosphonate administration for osteoporosis: A case report. J Med Case Rep. 2011 Sep 23;5:477
13. Vogt-Ferrier NB, Hugentobler M, Uebelhart B, Tramèr M, Rollason V. Interventions for treating osteonecrosis of the jaw bones associated with bisphosphonates (Protocol). Cochrane Database of Systematic Reviews 2010, Issue 4. Art. No.: CD008455. DOI: 10.1002/14651858.CD008455.
14. Wong YK. Bisphosphonate-related osteonecrosis of the jaws - Report of 2 cases and strategies on prevention and management. Quintessence Int. 2008 Mar;39(3):195-201.
15. Agrillo A, Filiaci F, Ramieri V, et al. Bisphosphonate-related osteonecrosis of the jaw (BRONJ): 5 year experience in the treatment of 131 cases with ozone therapy. European Review for Medical and Pharmacological Sciences. 2012;16:1741-1747.
16. Boeddinghaus R, Whyte A. Current concepts in maxillofacial imaging. European Journal of Radiology. 2008;66:396.
17. Torres SR, Chen CSK, Leroux BG, Lee PP, Hollender LG, Schubert MM. Fractal dimension evaluation of cone beam computed tomography in patients with bisphosphonate-associated osteonecrosis. Dentomaxillofacial Radiology. 2011;40:504.
18. Conte-Neto N, Bastos AS, Marcantonio RA, Junior EM. Epidemiological aspects of rheumatoid arthritis patients affected by oral bisphosphonaterelated osteonecrosis of the jaws. Head Face Med. 2012 Mar 1;8:5.
19. Sanna G, L Preda, R Bruschini, et al. Bisphosphonates and jaw osteonecrosis in patients with advanced breast cancer. Annals of Oncology. 2006;17:1512-1516.
20. del Castillo Pardo de Vera JL, García de Marcos JA, Rodríguez SA, Arenas MG, Calderón Polanco J. Osteonecrosis de los maxilares asociada al empleo de bifosfonatos Bisphosphonate-associated osteonecrosis of the jaw. Rev Esp Cir Oral y Maxilofac. 2007;29(5):295-308.
21. Wilde F, Heufelder M, Lorenz K, et al. MSCS, Rostock. Prevalence of cone beam computed tomography imaging findings according to the clinical stage of bisphosphonate-related osteonecrosis of the jaw. december 2012;114(6):805.
22. Treister N, Sheehy N, Bae EH, Friedland B, Lerman M, Woo S. Dental panoramic radiographic evaluation in bisphosphonate-associated osteonecrosis of the jaws. Oral Diseases. 2009;15:90-91.